Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.
2.

Bile salt excretory pump: biology and pathobiology.

Suchy FJ, Ananthanarayanan M.

J Pediatr Gastroenterol Nutr. 2006 Jul;43 Suppl 1:S10-6. Review.

PMID:
16819395
3.

Ligand-dependent activation of the farnesoid X-receptor directs arginine methylation of histone H3 by CARM1.

Ananthanarayanan M, Li S, Balasubramaniyan N, Suchy FJ, Walsh MJ.

J Biol Chem. 2004 Dec 24;279(52):54348-57.

4.

Role of FXR in regulating bile acid homeostasis and relevance for human diseases.

Rizzo G, Renga B, Mencarelli A, Pellicciari R, Fiorucci S.

Curr Drug Targets Immune Endocr Metabol Disord. 2005 Sep;5(3):289-303. Review.

PMID:
16178789
5.

Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters.

Hoeke MO, Plass JR, Heegsma J, Geuken M, van Rijsbergen D, Baller JF, Kuipers F, Moshage H, Jansen PL, Faber KN.

Hepatology. 2009 Jan;49(1):151-9. doi: 10.1002/hep.22661.

PMID:
19111018
6.

Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor.

Ananthanarayanan M, Balasubramanian N, Makishima M, Mangelsdorf DJ, Suchy FJ.

J Biol Chem. 2001 Aug 3;276(31):28857-65.

8.

Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis.

Fiorucci S, Clerici C, Antonelli E, Orlandi S, Goodwin B, Sadeghpour BM, Sabatino G, Russo G, Castellani D, Willson TM, Pruzanski M, Pellicciari R, Morelli A.

J Pharmacol Exp Ther. 2005 May;313(2):604-12.

9.

SUMOylation of the farnesoid X receptor (FXR) regulates the expression of FXR target genes.

Balasubramaniyan N, Luo Y, Sun AQ, Suchy FJ.

J Biol Chem. 2013 May 10;288(19):13850-62. doi: 10.1074/jbc.M112.443937.

10.

Bile acid nuclear receptor FXR and digestive system diseases.

Ding L, Yang L, Wang Z, Huang W.

Acta Pharm Sin B. 2015 Mar;5(2):135-44. doi: 10.1016/j.apsb.2015.01.004. Review.

11.

The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion.

Lew JL, Zhao A, Yu J, Huang L, De Pedro N, Peláez F, Wright SD, Cui J.

J Biol Chem. 2004 Mar 5;279(10):8856-61.

12.

Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.

Pineda Torra I, Claudel T, Duval C, Kosykh V, Fruchart JC, Staels B.

Mol Endocrinol. 2003 Feb;17(2):259-72.

PMID:
12554753
13.

The nuclear bile acid receptor FXR is activated by PGC-1alpha in a ligand-dependent manner.

Kanaya E, Shiraki T, Jingami H.

Biochem J. 2004 Sep 15;382(Pt 3):913-21.

15.

Farnesoid X receptor responds to bile acids and represses cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription.

Chiang JY, Kimmel R, Weinberger C, Stroup D.

J Biol Chem. 2000 Apr 14;275(15):10918-24.

17.

Guggulsterone is a farnesoid X receptor antagonist in coactivator association assays but acts to enhance transcription of bile salt export pump.

Cui J, Huang L, Zhao A, Lew JL, Yu J, Sahoo S, Meinke PT, Royo I, Pelaez F, Wright SD.

J Biol Chem. 2003 Mar 21;278(12):10214-20.

18.

1,25-dihydroxyvitamin D3 and its receptor inhibit the chenodeoxycholic acid-dependent transactivation by farnesoid X receptor.

Honjo Y, Sasaki S, Kobayashi Y, Misawa H, Nakamura H.

J Endocrinol. 2006 Mar;188(3):635-43.

19.

Nuclear receptor-mediated repression of human cholesterol 7alpha-hydroxylase gene transcription by bile acids.

Chen W, Owsley E, Yang Y, Stroup D, Chiang JY.

J Lipid Res. 2001 Sep;42(9):1402-12.

20.

Identification of DRIP205 as a coactivator for the Farnesoid X receptor.

Pineda Torra I, Freedman LP, Garabedian MJ.

J Biol Chem. 2004 Aug 27;279(35):36184-91.

Items per page

Supplemental Content

Support Center